Strong connections with Patient Advocacy Groups: trials designed with patients in mind.

Experience in working with ophthalmology sites to improve efficiency and protocol compliance.

Relationships with specialized vendors for ocular services: the right tools for your trial.

Experience matters when choosing a partner.

Experience counts when it comes to placing patients' needs at the forefront of your decisions and ensuring the success of your ophthalmology studies. Our expertise and insights at Fortrea have helped advance more than 110 clinical ophthalmology studies over the last five years as we’ve provided flexible solutions for emerging and mid-sized biotech companies.

In the last 5 years

We’ve been honored to serve as a CRO partner of choice for our biotech and pharmaceutical customers in the advancement of their ophthalmology therapies and supported:


Ophthalmology Studies





Our top areas of ophthalmology expertise:

Anterior Indications such as:

  • Glaucoma
  • Dry Eye Disease
  • Refractive Errors
  • Blepharitis

Posterior Indications such as:

  • Macular Degeneration
  • Rare Retinal Diseases
  • Retinopathy
  • Uveitis

Why choose Fortrea for your next Ophthalmology trial?

  • Experience as an industry leader gives us context to not just listen, but hear and respond to your needs 
  • Understanding of how to minimize site burden, to give your trial a competitive edge
  • A suite of tools to improve the patient and caregiver experience during your trial
  • Experienced team members, and our in-house Ophthalmology Academy gives us a pipeline of trained CRAs, PMs, and CTLs
  • Industry presence, including participation with Ocular Disease Forum, Mary Tyler Moore, RareX Vision Consortium focusing on the need for new endpoints.

Cell and Gene Therapies Rare Diseases Mobile Clinical Services

Get to know us

From working on over 100 ophthalmology studies in just the last 5 years alone, we understand the importance of a personalized approach to the unique challenges of ophthalmology including cell & gene therapies. We’re setting our teams up for success so they can successfully deliver life changing trials for patients with vision loss.

-Tanya Richardson, Executive Director & Global Lead, Strategic Delivery & Growth, Ophthalmology, Fortrea

Propel studies with robust patient recruitment, engagement and retention.

With a strategy tailored to each ocular disease indication, Fortrea’s holistic approach starts with established site relationships to find the strongest, high-performing sites for each study and leverage existing agreements to expedite startup. Our team of dedicated subject matter experts provides a comprehensive, data-driven site and patient engagement strategy that incorporates best practices gleaned from previous and current ophthalmology trial experience.

Your partner for comprehensive ophthalmology clinical trials.

Once your trial is underway, you can rely on Fortrea’s ocular clinical trial management team to provide close communication and collaboration. We work to identify certified vendors that perform visual acuity assessments and central reads of ocular imaging. We also use a highly flexible clinical platform for electronic patient-reported outcomes to provide high-quality data that enables you to stay connected to the progress of your program.

Fortrea has the tools to help improve health and lives by bringing vision treatments to market quickly and carefully.


Stay up to date:
Subscribe for Fortrea news & announcements.